ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance).

Saranya Chumsri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.